🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We’re focused on bringing in the best external science to complement our internal innovation and discovery efforts to deliver on our purpose and sustain our company for the next 130 years.

📢New Webinar Series Launch! Join us for the 1st edition of our new series: Ongoing Clinical Trials for BTC in Europe, hosted by Precision-BTC-Network (WG3), ENS-CCA and UKCCCR. 🗓️4 Sep 2025, 16:00 CET 🎙️Speaker Angela Lamarca 🎤Moderator Lorenza Rimassa 🔗precision-btc.eu/events/webinars

Join us for the Post-ASCO 2025 GI & ESMO Cancer Highlights! 🗓 Date: September 4, 2025 🕕 Time: 18:00–20:00 CEST | 11:00–13:00 CDT | 17:00–19:00 BST Don’t miss this expert-led webinar hosted by VJ Oncology , diving into key abstracts and breakthroughs in GI cancer from ASCO

Ongoing clinical trials for #BTC in Europe #COST action webinar series Precision-BTC-Network ENS-CCA Angela Lamarca

👉 Shape the future of oncology! ⏰ Submit your abstract for ESMO Asia 2025 by 12 August. Join the Asia Pacific cancer research community in Singapore this December and get published in Annals of Oncology (IF 56.7)! #ESMOAsia25 🔗 ow.ly/xBeC50W7xB0

Detailed review on immune microenvironment in HCC. doi.org/10.1038/s41423… @arndtvogel James J. Harding, MD Changhoon Yoo, MD Angela Lamarca @gaboualfa Mark Yarchoan Maria Reig Antonio D'Alessio Lorenza Rimassa ElePalma

Yesterday, I met with a 12-year-old boy in Oxnard, CA. His mom and dad have been fieldworkers for over 20 years. ICE agents snatched his parents from the fields and left this boy alone with no clue when he’ll see them again. A 6th grader.

🎯 Changing the Game in HCC: How We Move Patients Toward Cure through "Converse Therapeutic Hierarchy" — a flexible framework to guide sequential, personalised treatment for #HCC. andrea casadei gardini Lorenza Rimassa Giuseppe Cabibbo Francesca Romana Ponziani karger.com/lic/article/do…

ESMO announces the 2025 election results for the Director positions & the Nomination Committee. Thank you to all #ESMOMembers who voted & contributed to shaping the Society’s future direction 📢Curious to see who was elected? 🔗Read the full announcement ow.ly/fJgs50W92CJ

Congrats Lizzy Smyth elected ESMO - Eur. Oncology Director of Education! 👏🏻👏🏻👏🏻

🔬Clinical relevance of histological heterogeneity of cholangiocarcinoma HEPATOLOGY Journal 👏🏻🎉Congrats to all authors and ENS-CCA Precision-BTC-Network for this wonderful study. Thanks for their priceless contributions to the biliary cancer research! 🚨PAS-high, large bile-duct,

La XXIII Conferenza Nazionale AIOM vi aspetta a Bologna il 20 e il 21 giugno. Qui il programma preliminare: aiom.it/wp-content/upl… #AIOM #eventiaiom #conferenzanazionaleaiom

🚨New milestone in CCA research! Explore the European Histological Registry and its first publication🧬 🔗pubmed.ncbi.nlm.nih.gov/40513068/ 📊~300 cases from 6 countries, with clinical data & growing collaborations. Want to contribute or use the data? Contact coordinator Guido Carpino

📣 #ESMO25: A place to transform the way you treat cancer. Discover innovations and collaborate with experts to advance your practice. ⏰ Register today! Early registration deadline: 16 July 2025 🔗 ow.ly/GGjj50W7zwp

ESMO - Eur. Oncology - Gastrointestinal Cancers Congress 2025: Late-breaking titles have been released. Explore insights from oncology conferences, top clinical trials, and reactions from oncologists: clin.larvol.com #LARVOL #ESMOGI25 #GastrointestinalCancers #GICancer #Oncology

📣 Barcelona is calling! Join the global GI oncology community at the ESMO Gastrointestinal Cancers Congress 2025, 2–5 July, in Barcelona. Science. Innovation. Collaboration. Still time to register! #ESMOGI25 🔗 ow.ly/XCQ950W9RlW

A new Diary of an Oncology Leader video is out. In this episode, Marina Garassino shares her thoughts on her journey overseas, the founding of W4O Italy and the leadership lessons that shaped her path Watch now for inspiration 🔗 ow.ly/V6uV50Waztg #W4O #OncologyLeadership

👉 After progression on 1st line IO, multiple treatment strategies are available in advanced HCC 👉 If a clinical trial is not available, switching to a TKI or considering alternative IO-based approaches may be viable options based on: ✅ patient eligibility ✅ disease

🎯 Have questions about Biliary Tract Cancers? Join the PeerVoice CME-accredited symposium chaired by Lorenza Rimassa at #ESMOGI25 in Barcelona! 📅 July 2, 2025 ⏰ 11:30 AM CEST 📍 CCIB, Room Malaga 🔗 peervoice.com/BTCs-Barca25 #Oncology #CME #BTC #MedicalEducation

Please join us! PeerVoice symposium on #BTC #CCA at #ESMOGI25 ESMO - Eur. Oncology Humanitas University Humanitas Milano